In a bid to save lives, AstraZeneca Philippines has signed an agreement with Security Bank Corporation and SB Finance to provide cancer patients with easier funding options for diagnostics and long-term treatment. In a statement, Security Bank said the Cancer Care Ecosystem Funding Partnership is p
(Photo by Paul ELLIS / AFP / MANILA BULLETIN)
With the FDA’s approval, Dapagliflozin is the first and only drug under the sodium glucose transport protein 2 inhibitor (SGLT2i) class approved to treat heart failure in adult patients with reduced ejection fraction (pumapalyang puso), AstraZeneca Philippines said in statement.
The multinational pharmaceutical company noted that the Dapagliflozin, a medicine for diabetes, is the only SGLT2i proven to significantly prevent cardiovascular death and death due to other causes among patients with heart failure.
AstraZeneca Philippines Country President Lotis Ramin expressed AstraZeneca’s commitment to uplift the standard of care of Filipino patients by providing them with innovative and accessible treatment.
January 28, 2021 | 8:03 pm Font Size
Image via Reuters
THE LOCAL Food and Drug Administration (FDA) has approved the emergency use of AstraZeneca Plcâs coronavirus vaccine in the Philippines, the second approval after Pfizer, Inc.
Evidence and data show it is reasonable to believe that the vaccine might be effective against the coronavirus disease 2019 (COVID-19) virus, FDA Director General Rolando Enrique D. Domingo told an online news briefing on Thursday. The benefits outweigh potential risks, he added.
The vaccine had no safety concerns and its adverse effects were âtransient and mostly mild to moderate, similar to common vaccine reactions,â he said.